MedTrace Logo

Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

NCT00819026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2014-12-10

No results posted yet for this study

Summary

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.

Conditions

  • Hepatitis C Virus

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Robert Striker · University of Wisconsin, Madison

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00819026 on ClinicalTrials.gov